Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atropine 1% eye drops 0.5ml unit dose preservative free
1105000B0AAAJAJ
|
Atropine sulfate (Eye) | Atropine sulfate | Eye | 9,295 |
|
Atropine 1% eye drops
1105000B0AAAEAE
|
Atropine sulfate (Eye) | Atropine sulfate | Eye | 7,676 |
|
Minims atropine sulfate 1% eye drops 0.5ml unit dose
1105000B0BBAAAJ
|
Minims atropine sulfate | Atropine sulfate | Eye | 1,766 |
|
Atropine 600micrograms/1ml solution for injection ampoules
1501030D0AAAPAP
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | 12 |
|
Atropine 500micrograms/5ml oral solution
0102000ACAABABA
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | 11 |
|
Atropine 3mg/10ml solution for injection pre-filled syringes
1501030D0AABDBD
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | 5 |
|
Atropine 1mg/1ml solution for injection ampoules
1501030D0AAARAR
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | 2 |
|
Atropine 600microgram tablets
0102000ACAAAGAG
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | 2 |
|
Atropine 500micrograms/5ml oral suspension
0102000ACAAAPAP
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | 1 |
|
Atropine 0.5% eye drops
1105000B0AAADAD
|
Atropine sulfate (Eye) | Atropine sulfate | Eye | No data available |
|
Atropine 1.25mg/1ml solution for injection ampoules
1501030D0AAASAS
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | No data available |
|
Atropine 1% eye drops preservative free
1105000B0AAANAN
|
Atropine sulfate (Eye) | Atropine sulfate | Eye | No data available |
|
Atropine 1% eye ointment
1105000B0AAAHAH
|
Atropine sulfate (Eye) | Atropine sulfate | Eye | No data available |
|
Atropine 100micrograms/5ml oral solution
0102000ACAAAVAV
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | No data available |
|
Atropine 150micrograms/5ml oral solution
0102000ACAAAXAX
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | No data available |
|
Atropine 1mg/10ml inj Minijet pre-filled syringes
1501030D0BBABA2
|
Minjet atropine sulfate | Atropine sulfate | Anaesthesia | No data available |
|
Atropine 1mg/10ml solution for injection pre-filled syringes
1501030D0AAA2A2
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | No data available |
|
Atropine 1mg/5ml solution for injection pre-filled syringes
1501030D0AABHBH
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | No data available |
|
Atropine 200micrograms/5ml oral solution
0102000ACAAAQAQ
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | No data available |
|
Atropine 250micrograms/5ml oral liquid
0102000ACAAAZAZ
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | No data available |
|
Atropine 300micrograms/5ml oral liquid
0102000ACAAASAS
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | No data available |
|
Atropine 3mg/10ml solution for injection ampoules
1501030D0AAAAAA
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | No data available |
|
Atropine 3mg/30ml inj Minijet pre-filled syringes
1501030D0BBADBB
|
Minjet atropine sulfate | Atropine sulfate | Anaesthesia | No data available |
|
Atropine 3mg/30ml solution for injection pre-filled syringes
1501030D0AABBBB
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | No data available |
|
Atropine 400micrograms/1ml solution for injection ampoules
1501030D0AAAIAI
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.